Concepts (335)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Viral | 25 | 2026 | 306 | 3.950 |
Why?
|
| West Nile virus | 7 | 2025 | 78 | 2.390 |
Why?
|
| West Nile Fever | 8 | 2025 | 68 | 2.290 |
Why?
|
| Viral Vaccines | 9 | 2022 | 37 | 2.270 |
Why?
|
| Deer | 5 | 2025 | 16 | 2.150 |
Why?
|
| Aedes | 5 | 2025 | 43 | 2.050 |
Why?
|
| Rift Valley Fever | 3 | 2022 | 8 | 1.970 |
Why?
|
| Dengue | 10 | 2026 | 107 | 1.900 |
Why?
|
| Dengue Virus | 9 | 2026 | 96 | 1.760 |
Why?
|
| Texas | 14 | 2025 | 457 | 1.730 |
Why?
|
| Rift Valley fever virus | 4 | 2022 | 9 | 1.610 |
Why?
|
| Seroepidemiologic Studies | 10 | 2026 | 74 | 1.360 |
Why?
|
| Culex | 3 | 2025 | 10 | 1.200 |
Why?
|
| Culicidae | 8 | 2019 | 26 | 1.190 |
Why?
|
| Mexico | 7 | 2025 | 298 | 1.170 |
Why?
|
| Swine Diseases | 2 | 2025 | 9 | 1.110 |
Why?
|
| Flavivirus | 3 | 2025 | 16 | 1.100 |
Why?
|
| Flavivirus Infections | 2 | 2025 | 5 | 1.090 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 4 | 2022 | 11 | 1.060 |
Why?
|
| Animals | 55 | 2026 | 16992 | 1.050 |
Why?
|
| Antibodies, Neutralizing | 9 | 2023 | 127 | 0.980 |
Why?
|
| Rickettsia typhi | 1 | 2025 | 1 | 0.930 |
Why?
|
| Ticks | 1 | 2025 | 8 | 0.930 |
Why?
|
| Rickettsia rickettsii | 1 | 2025 | 3 | 0.930 |
Why?
|
| Reoviridae Infections | 1 | 2025 | 1 | 0.910 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2025 | 3 | 0.910 |
Why?
|
| Thogotovirus | 1 | 2025 | 2 | 0.910 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2025 | 3 | 0.910 |
Why?
|
| DNA Virus Infections | 1 | 2025 | 16 | 0.900 |
Why?
|
| Oviposition | 1 | 2024 | 14 | 0.890 |
Why?
|
| Leptospirosis | 3 | 2022 | 31 | 0.830 |
Why?
|
| Malaria | 3 | 2022 | 90 | 0.820 |
Why?
|
| Serologic Tests | 2 | 2020 | 45 | 0.810 |
Why?
|
| Arboviruses | 2 | 2022 | 8 | 0.780 |
Why?
|
| Peru | 18 | 2022 | 41 | 0.650 |
Why?
|
| Aotidae | 2 | 2019 | 4 | 0.620 |
Why?
|
| Sentinel Surveillance | 1 | 2019 | 25 | 0.600 |
Why?
|
| Goat Diseases | 1 | 2019 | 6 | 0.600 |
Why?
|
| Seasons | 6 | 2025 | 139 | 0.570 |
Why?
|
| Cattle | 1 | 2019 | 498 | 0.550 |
Why?
|
| Population Density | 5 | 2025 | 38 | 0.510 |
Why?
|
| Immunoglobulin G | 3 | 2025 | 259 | 0.490 |
Why?
|
| Female | 27 | 2026 | 24698 | 0.490 |
Why?
|
| Cities | 3 | 2025 | 79 | 0.460 |
Why?
|
| Humans | 42 | 2026 | 43102 | 0.450 |
Why?
|
| Insect Vectors | 7 | 2021 | 27 | 0.430 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 1596 | 0.380 |
Why?
|
| Vaccines, Attenuated | 3 | 2022 | 75 | 0.380 |
Why?
|
| Floods | 1 | 2011 | 6 | 0.360 |
Why?
|
| Chagas Disease | 2 | 2022 | 104 | 0.330 |
Why?
|
| Trypanosoma cruzi | 2 | 2022 | 157 | 0.320 |
Why?
|
| Tanzania | 2 | 2019 | 28 | 0.300 |
Why?
|
| Protein Subunits | 1 | 2008 | 93 | 0.280 |
Why?
|
| Alphavirus Infections | 2 | 2006 | 7 | 0.280 |
Why?
|
| Alphavirus | 2 | 2006 | 10 | 0.280 |
Why?
|
| Disease Vectors | 3 | 2012 | 11 | 0.280 |
Why?
|
| Pregnancy | 3 | 2025 | 1772 | 0.280 |
Why?
|
| Desert Climate | 2 | 2024 | 14 | 0.270 |
Why?
|
| Dogs | 3 | 2025 | 204 | 0.270 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 518 | 0.270 |
Why?
|
| Mice | 12 | 2025 | 6644 | 0.270 |
Why?
|
| Phylogeny | 6 | 2024 | 769 | 0.270 |
Why?
|
| Animals, Wild | 2 | 2025 | 24 | 0.270 |
Why?
|
| Urban Population | 2 | 2024 | 374 | 0.260 |
Why?
|
| Male | 19 | 2026 | 23409 | 0.260 |
Why?
|
| Anopheles | 3 | 2012 | 21 | 0.260 |
Why?
|
| Swine | 2 | 2025 | 212 | 0.260 |
Why?
|
| Vero Cells | 8 | 2024 | 112 | 0.250 |
Why?
|
| Monkey Diseases | 1 | 2026 | 7 | 0.240 |
Why?
|
| Interferon-beta | 2 | 2025 | 9 | 0.240 |
Why?
|
| Mice, Transgenic | 4 | 2025 | 665 | 0.240 |
Why?
|
| Disease Reservoirs | 1 | 2026 | 25 | 0.240 |
Why?
|
| Pupa | 2 | 2024 | 6 | 0.240 |
Why?
|
| Meteorological Concepts | 1 | 2025 | 5 | 0.240 |
Why?
|
| Larva | 3 | 2024 | 133 | 0.240 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2025 | 2 | 0.230 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2025 | 3 | 0.230 |
Why?
|
| Encephalomyelitis, Venezuelan Equine | 2 | 2020 | 3 | 0.230 |
Why?
|
| Chikungunya virus | 2 | 2018 | 18 | 0.230 |
Why?
|
| Bunyaviridae | 1 | 2025 | 5 | 0.230 |
Why?
|
| Sus scrofa | 1 | 2025 | 19 | 0.230 |
Why?
|
| Ecthyma, Contagious | 1 | 2024 | 1 | 0.220 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 117 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2020 | 458 | 0.220 |
Why?
|
| Cricetinae | 7 | 2012 | 241 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 4 | 2022 | 694 | 0.210 |
Why?
|
| Senegal | 6 | 2026 | 7 | 0.210 |
Why?
|
| Severe Acute Respiratory Syndrome | 3 | 2009 | 7 | 0.210 |
Why?
|
| Encephalitis Virus, Eastern Equine | 3 | 2010 | 3 | 0.210 |
Why?
|
| Adult | 11 | 2025 | 13872 | 0.200 |
Why?
|
| Viral Load | 1 | 2025 | 348 | 0.200 |
Why?
|
| Mothers | 1 | 2025 | 215 | 0.190 |
Why?
|
| Poxviridae | 1 | 2022 | 1 | 0.190 |
Why?
|
| Family | 1 | 2004 | 195 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 1869 | 0.190 |
Why?
|
| Genome, Viral | 2 | 2020 | 119 | 0.190 |
Why?
|
| Virus Replication | 5 | 2019 | 318 | 0.190 |
Why?
|
| Rivers | 1 | 2022 | 51 | 0.190 |
Why?
|
| Infant, Newborn | 1 | 2025 | 972 | 0.190 |
Why?
|
| Fever | 1 | 2022 | 62 | 0.190 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 719 | 0.180 |
Why?
|
| Orthobunyavirus | 2 | 2011 | 5 | 0.170 |
Why?
|
| Cluster Analysis | 2 | 2012 | 207 | 0.170 |
Why?
|
| Triatoma | 1 | 2021 | 5 | 0.170 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2021 | 3 | 0.170 |
Why?
|
| Geography | 6 | 2012 | 110 | 0.170 |
Why?
|
| Reassortant Viruses | 2 | 2011 | 11 | 0.160 |
Why?
|
| Yellow fever virus | 2 | 2013 | 3 | 0.150 |
Why?
|
| Arbovirus Infections | 2 | 2019 | 6 | 0.150 |
Why?
|
| Goats | 1 | 2019 | 23 | 0.150 |
Why?
|
| Serial Passage | 2 | 2022 | 5 | 0.150 |
Why?
|
| Young Adult | 5 | 2025 | 5080 | 0.150 |
Why?
|
| Bunyaviridae Infections | 2 | 2011 | 7 | 0.140 |
Why?
|
| Biodiversity | 1 | 2019 | 111 | 0.140 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2009 | 35 | 0.140 |
Why?
|
| RNA Viruses | 2 | 2019 | 22 | 0.140 |
Why?
|
| Virology | 1 | 2017 | 8 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 209 | 0.130 |
Why?
|
| Yellow Fever | 2 | 2010 | 5 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 333 | 0.130 |
Why?
|
| Mesocricetus | 4 | 2010 | 56 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 32 | 0.130 |
Why?
|
| Encephalomyelitis, Equine | 2 | 2007 | 2 | 0.120 |
Why?
|
| Climate | 2 | 2014 | 22 | 0.120 |
Why?
|
| RNA, Viral | 5 | 2024 | 321 | 0.120 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 55 | 0.120 |
Why?
|
| Epitopes | 1 | 2016 | 157 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 184 | 0.120 |
Why?
|
| Ecosystem | 3 | 2012 | 175 | 0.120 |
Why?
|
| Sciuridae | 2 | 2005 | 6 | 0.110 |
Why?
|
| Monkeypox virus | 2 | 2005 | 3 | 0.110 |
Why?
|
| Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hemorrhagic Fever, Crimean | 1 | 2013 | 1 | 0.100 |
Why?
|
| Viral Structural Proteins | 1 | 2013 | 17 | 0.100 |
Why?
|
| Nucleocapsid Proteins | 1 | 2013 | 12 | 0.100 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 29 | 0.100 |
Why?
|
| Insect Viruses | 1 | 2012 | 3 | 0.100 |
Why?
|
| Phlebotomus | 1 | 2012 | 2 | 0.100 |
Why?
|
| Antigens, Viral | 1 | 2013 | 48 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2013 | 42 | 0.100 |
Why?
|
| Middle Aged | 8 | 2021 | 12222 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2013 | 91 | 0.090 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2013 | 53 | 0.090 |
Why?
|
| Vaccines, Synthetic | 3 | 2008 | 80 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 2003 | 175 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 35 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 3156 | 0.090 |
Why?
|
| Neutralization Tests | 5 | 2012 | 57 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2012 | 863 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2011 | 162 | 0.090 |
Why?
|
| Viremia | 2 | 2008 | 44 | 0.090 |
Why?
|
| Environment | 1 | 2012 | 149 | 0.090 |
Why?
|
| Cell Line | 4 | 2019 | 1410 | 0.080 |
Why?
|
| Encephalomyelitis, Eastern Equine | 1 | 2010 | 1 | 0.080 |
Why?
|
| Sigmodontinae | 1 | 2010 | 2 | 0.080 |
Why?
|
| Sparrows | 1 | 2010 | 4 | 0.080 |
Why?
|
| Data Collection | 1 | 2011 | 210 | 0.080 |
Why?
|
| Primates | 2 | 2026 | 39 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 515 | 0.080 |
Why?
|
| Horse Diseases | 1 | 2010 | 11 | 0.080 |
Why?
|
| Yellow Fever Vaccine | 1 | 2010 | 2 | 0.080 |
Why?
|
| Base Sequence | 4 | 2020 | 983 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2011 | 1285 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2011 | 587 | 0.080 |
Why?
|
| Venezuela | 2 | 2012 | 8 | 0.080 |
Why?
|
| Proteomics | 1 | 2012 | 378 | 0.080 |
Why?
|
| Proteins | 1 | 2012 | 382 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 25 | 0.070 |
Why?
|
| Weaning | 1 | 2008 | 16 | 0.070 |
Why?
|
| Appetitive Behavior | 1 | 2008 | 16 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 26 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 59 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 1009 | 0.070 |
Why?
|
| Cross Reactions | 3 | 2021 | 87 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2024 | 455 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 94 | 0.070 |
Why?
|
| Sindbis Virus | 1 | 2008 | 14 | 0.070 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Encephalitis, St. Louis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Viral Envelope Proteins | 1 | 2007 | 91 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2024 | 430 | 0.060 |
Why?
|
| Endemic Diseases | 1 | 2007 | 23 | 0.060 |
Why?
|
| Vaccines, Subunit | 1 | 2006 | 34 | 0.060 |
Why?
|
| Molecular Epidemiology | 2 | 2003 | 59 | 0.060 |
Why?
|
| Time Factors | 2 | 2008 | 1857 | 0.060 |
Why?
|
| Horses | 2 | 2020 | 28 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2007 | 224 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 1180 | 0.060 |
Why?
|
| Spleen | 4 | 2009 | 204 | 0.060 |
Why?
|
| Interferons | 1 | 2005 | 40 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 734 | 0.060 |
Why?
|
| Vaccination | 1 | 2007 | 355 | 0.060 |
Why?
|
| Orthopoxvirus | 1 | 2024 | 1 | 0.060 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2024 | 14 | 0.060 |
Why?
|
| Morocco | 1 | 2024 | 16 | 0.060 |
Why?
|
| Sheep | 1 | 2024 | 77 | 0.050 |
Why?
|
| Genome, Insect | 1 | 2024 | 11 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1542 | 0.050 |
Why?
|
| Dendritic Cells | 2 | 2016 | 132 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2004 | 86 | 0.050 |
Why?
|
| Ceratopogonidae | 1 | 2003 | 1 | 0.050 |
Why?
|
| Mississippi | 1 | 2024 | 129 | 0.050 |
Why?
|
| Bites and Stings | 1 | 2003 | 13 | 0.050 |
Why?
|
| Kinetics | 2 | 2019 | 695 | 0.050 |
Why?
|
| Skin | 1 | 2024 | 187 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 207 | 0.050 |
Why?
|
| Aging | 1 | 2008 | 783 | 0.050 |
Why?
|
| Serotyping | 3 | 2012 | 37 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2024 | 311 | 0.050 |
Why?
|
| Trisaccharides | 1 | 2022 | 11 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2012 | 1546 | 0.050 |
Why?
|
| Prevalence | 2 | 2021 | 1612 | 0.050 |
Why?
|
| Military Personnel | 1 | 2003 | 110 | 0.050 |
Why?
|
| Mucins | 1 | 2022 | 73 | 0.050 |
Why?
|
| Incidence | 3 | 2012 | 1078 | 0.050 |
Why?
|
| Adolescent | 5 | 2012 | 6081 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 117 | 0.040 |
Why?
|
| Cytokines | 3 | 2012 | 678 | 0.040 |
Why?
|
| New Mexico | 1 | 2021 | 37 | 0.040 |
Why?
|
| Cats | 1 | 2021 | 82 | 0.040 |
Why?
|
| Mammals | 1 | 2021 | 112 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2003 | 326 | 0.040 |
Why?
|
| Housing | 2 | 2012 | 74 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2019 | 29 | 0.040 |
Why?
|
| Demography | 3 | 2004 | 195 | 0.040 |
Why?
|
| Child | 3 | 2012 | 3443 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 186 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 189 | 0.040 |
Why?
|
| Haplorhini | 1 | 2018 | 23 | 0.040 |
Why?
|
| Africa | 1 | 2018 | 82 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 293 | 0.030 |
Why?
|
| Malaysia | 1 | 2017 | 10 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 1600 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 1063 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2009 | 124 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2021 | 469 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2016 | 74 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 1759 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 701 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 74 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 478 | 0.030 |
Why?
|
| Rain | 1 | 2014 | 10 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 2853 | 0.030 |
Why?
|
| DNA Primers | 2 | 2006 | 294 | 0.030 |
Why?
|
| HLA-A2 Antigen | 1 | 2013 | 4 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 83 | 0.020 |
Why?
|
| Lentivirus | 1 | 2013 | 24 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 121 | 0.020 |
Why?
|
| Primate Diseases | 1 | 2012 | 4 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1082 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 135 | 0.020 |
Why?
|
| Leptospira | 2 | 2003 | 27 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 60 | 0.020 |
Why?
|
| Lung | 2 | 2006 | 492 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 165 | 0.020 |
Why?
|
| Sporozoites | 1 | 2012 | 6 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 25 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 51 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 115 | 0.020 |
Why?
|
| Trees | 1 | 2012 | 22 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 78 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 416 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2012 | 68 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 102 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 411 | 0.020 |
Why?
|
| Fluorescence | 1 | 2012 | 118 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 195 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2009 | 1455 | 0.020 |
Why?
|
| Liver | 2 | 2005 | 511 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 238 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 193 | 0.020 |
Why?
|
| Bolivia | 1 | 2010 | 9 | 0.020 |
Why?
|
| South America | 1 | 2010 | 24 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 440 | 0.020 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2010 | 14 | 0.020 |
Why?
|
| North America | 1 | 2010 | 85 | 0.020 |
Why?
|
| Fever of Unknown Origin | 1 | 2010 | 7 | 0.020 |
Why?
|
| Absenteeism | 1 | 2010 | 14 | 0.020 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 18 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 638 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2010 | 65 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2010 | 44 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 286 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 241 | 0.020 |
Why?
|
| Risk Factors | 2 | 2012 | 3994 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 876 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2009 | 10 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 141 | 0.020 |
Why?
|
| HIV Infections | 1 | 2003 | 2586 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2009 | 63 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1175 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 166 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 8214 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 21 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 18 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2007 | 18 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2007 | 76 | 0.020 |
Why?
|
| Brain | 2 | 2006 | 1472 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2007 | 8 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2007 | 8 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2007 | 272 | 0.020 |
Why?
|
| Carrier State | 1 | 2007 | 33 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1154 | 0.020 |
Why?
|
| Immunization | 1 | 2007 | 94 | 0.020 |
Why?
|
| Point Mutation | 1 | 2007 | 98 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2006 | 76 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 74 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 117 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2005 | 14 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2005 | 43 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 652 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1766 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 306 | 0.010 |
Why?
|
| Rodent Diseases | 1 | 2004 | 13 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 934 | 0.010 |
Why?
|
| Insect Bites and Stings | 1 | 2004 | 3 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2004 | 11 | 0.010 |
Why?
|
| Urban Health | 1 | 2004 | 101 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2005 | 269 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 101 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 80 | 0.010 |
Why?
|
| Heart | 1 | 2005 | 184 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2005 | 195 | 0.010 |
Why?
|
| HIV Seroprevalence | 1 | 2003 | 11 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2002 | 12 | 0.010 |
Why?
|
| Chickens | 1 | 2004 | 161 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 236 | 0.010 |
Why?
|
| Plants | 1 | 2003 | 113 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 3735 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2005 | 1035 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 490 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 800 | 0.010 |
Why?
|